ClassID:

95846 āŽ˜

C07F9/117 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds without P—C bonds; Esters of oxyacids of phosphorus; Esters of phosphoric acids with cycloaliphatic alcohols

Recent Application in this class:
#1
20250346615
2025-11-13

GLYCEROPHOSPHOINOSITOL IN PREVENTING AND TREATING COVID-19 INFECTIONS AND METHOD FOR OBTAINING IT

#2
20250215028
2025-07-03

SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS

#3
20250108064
2025-04-03

PHOSPHATE PRODRUGS OF CANNABINOIDS

#4
20250042924
2025-02-06

WATER-SOLUBLE PHYTIN

#5
20240331952
2024-10-03

Formation Electrolyte for Tantalum Solid Electrolyte Capacitors

#6
20230381307
2023-11-30

TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#7
20230159502
2023-05-25

INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#8
20220331346
2022-10-20

Substituted bicyclic compounds

#9
20220289660
2022-09-15

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#10
20220227776
2022-07-21

PRODRUGS OF 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGUES FOR ANTIVIRAL TREATMENT

#11
20220024845
2022-01-27

Compounds and methods for delivery of prostacyclin analogs

#12
20210395175
2021-12-23

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#13
20210353651
2021-11-18

Compounds, derivatives, and analogs for cancer

#14
20210188999
2021-06-24

ABCB5 LIGANDS AND SUBSTRATES

#15
20200281952
2020-09-10

Substituted bicyclic compounds

#16
20200268882
2020-08-27

Treatment of autism spectrum disorder and associated symptoms

#17
20200189999
2020-06-18

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#18
20200181057
2020-06-11

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#19
20200157127
2020-05-21

Phospholipid analogues

#20
20200140468
2020-05-07

Limonene-based, non-halogenated flame retardants for polymeric applications

#21
20190351054
2019-11-21

Treatment of autism spectrum disorder and associated symptoms

#22
20190345091
2019-11-14

Compounds and methods for delivery of prostacyclin analogs

#23
20190298859
2019-10-03

Endosomolytic agents for gene therapy

#24
20190284217
2019-09-19

NOVEL COMPOUND, COMPOSITION INCLUDING SAME, OLEFIN-BASED RESIN COMPOSITION, MOLDED ARTICLE THEREOF, AND METHOD FOR IMPROVING IMPACT RESISTANCE OF MOLDED ARTICLE

#25
20190263742
2019-08-29

Hydroxyl compounds and compositions for cholesterol management and related uses

#26
20190218193
2019-07-18

Substituted tricyclic heterocyclic compounds

#27
20190201430
2019-07-04

TREATING OCULAR NEOVASCULARIZATION

#28
20190177347
2019-06-13

Ladderane lipid compounds and liposomes and methods of preparing and using the same

#29
20190084908
2019-03-21

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#30
20190076450
2019-03-14

Substituted bicyclic compounds

#31
20190071566
2019-03-07

Phosphorus compounds, synthesis method thereof, and polycarbonate resin composition including them

#32
20180141891
2018-05-24

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#33
20170349516
2017-12-07

Hydroxyl compounds and compositions for cholesterol management and related uses

#34
20170348417
2017-12-07

TREATMENT OF ATTENTION DEFICIT DISORDERS AND ASSOCIATED SYMPTOMS

#35
20170304332
2017-10-26

Substituted bicyclic compounds

#36
20170298083
2017-10-19

NEW IMMUNOSTIMULATORY COMPOUNDS

#37
20170275311
2017-09-28

Non-aqueous liquid electrolyte, electricity storage device using same, and phosphorus compound used therein

#38
20170260072
2017-09-14

Method and devices for de-emulsifying and complexing organic compounds in emulsions

#39
20170073286
2017-03-16

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#40
20170042926
2017-02-16

Treating ocular neovascularization

#41
20170042917
2017-02-16

Substituted bicyclic compounds

#42
20170029449
2017-02-02

Method for acquiring one or a plurality of recyclable materials from seeds

#43
20160355455
2016-12-08

Compounds and methods for delivery of prostacyclin analogs

#44
20160325205
2016-11-10

Methods of extracting phosphorus from distillates

#45
20160280727
2016-09-29

Pharmaceutical compounds for use in the therapy of clostridium difficile infection

#46
20160052888
2016-02-25

Substituted bicyclic compounds

#47
20160052862
2016-02-25

Nitroso compounds as nitroxyl donors and methods of use thereof

#48
20160051505
2016-02-25

Compounds and methods for delivery of prostacyclin analogs

#49
20160030371
2016-02-04

Compounds and methods for delivery of prostacyclin analogs

#50
20160016979
2016-01-21

Process for manufacture of gadofosveset trisodium monohydrate

#51
20150376213
2015-12-31

Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring

#52
20150344389
2015-12-03

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#53
20150344388
2015-12-03

Hydroxyl compounds and compositions for cholesterol management and related uses

#54
20150315128
2015-11-05

Bicyclic compounds

#55
20150259274
2015-09-17

Compounds and methods for delivery of prostacyclin analogs

#56
20150241449
2015-08-27

Molecularly imprinted polymer for detection of pentraxin protein and method for preparing the same

#57
20150005374
2015-01-01

Compounds and methods for delivery of prostacyclin analogs

#58
20140350288
2014-11-27

Synthesis of galanal compounds and analogues thereof

#59
20140336137
2014-11-13

Nitroso compounds as nitroxyl donors and methods of use thereof

#60
20140235723
2014-08-21

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#61
20140235591
2014-08-21

Tetrahydronaphthalenyl compounds useful as sipi agonists

#62
20140235590
2014-08-21

Pharmaceutical compounds for use in the therapy of infection

#63
20140170127
2014-06-19

Inositol pyrophosphates, and methods of use thereof

#64
20140066409
2014-03-06

Cyclohexane compounds and their use as antibiotics

#65
20140045799
2014-02-13

Inositol hexakisphosphate analogs and uses thereof

#66
20130289117
2013-10-31

Hydroxyl compounds and compositions for cholesterol management and related uses

#67
20130261187
2013-10-03

Compounds and methods for delivery of prostacyclin analogs

#68
20130202689
2013-08-08

NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS

#69
20130059820
2013-03-07

INOSITOL PYROPHOSPHATES, AND METHODS OF USE THEREOF

#70
20130045951
2013-02-21

Nitroso compounds as nitroxyl donors and methods of use thereof

#71
20130040916
2013-02-14

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#72
20120295980
2012-11-22

Compounds and methods for delivery of prostacyclin analogs

#73
20120277196
2012-11-01

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#74
20120258936
2012-10-11

INOSITOL HEXAKISPHOSPHATE ANALOGS AND USES THEREOF

#75
20120225908
2012-09-06

Hydroxyl compounds and compositions for cholesterol management and related uses

#76
20120172337
2012-07-05

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#77
20120128536
2012-05-24

Molecularly imprinted polymer for detecting the pentraxin, and method for preparing same

#78
20120065172
2012-03-15

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#79
20120035141
2012-02-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#80
20120028922
2012-02-02

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#81
20110281825
2011-11-17

Inositol pyrophosphates, and methods of use thereof

#82
20110118213
2011-05-19

Compounds and methods for delivery of prostacyclin analogs

#83
20110040108
2011-02-17

Inositolphospholipids and analogues phosphatidylinositol products and processes

#84
20110003860
2011-01-06

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#85
20100317890
2010-12-16

L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same

#86
20100256094
2010-10-07

Inositol pyrophosphates, and methods of use thereof

#87
20100221809
2010-09-02

Compositions and Methods for the Isolation of Biologically Active Proteins

#88
20100216638
2010-08-26

Herbicidally active bicyclic 1,3-dione compounds

#89
20090281062
2009-11-12

Nitroso compounds as nitroxyl donors and methods of use thereof

#90
20090247489
2009-10-01

Dihydroxyl compounds and compositions for cholesterol management and related uses

#91
20090221531
2009-09-03

Phytic citrate compounds and process for preparing the same

#92
20090175914
2009-07-09

Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof

#93
20090137393
2009-05-28

2,4,6-trialkylphenyl substituted cyclopentane-1,3-dione

#94
20080293667
2008-11-27

Lipid analogs for combating tumors

#95
20080261237
2008-10-23

Inositol-phosphate derivatives and method of detecting inositol-1-phosphate

#96
20080249167
2008-10-09

Compounds and methods for delivery of prostacyclin analogs

#97
20080249166
2008-10-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#98
20080132713
2008-06-05

Probe for measuring phytase activity

#99
20080118817
2008-05-22

Additive of electrode for fuel cell, electrode for fuel cell including the same, manufacturing method thereof, and fuel cell using the same

#100
20080071116
2008-03-20

Modulators of Lysophosphatidic Acid (Lpa) Signaling and the Use Thereof

#101
20080064661
2008-03-13

Dihydroxyl compounds and compositions for cholesterol management and related uses

#102
20070260076
2007-11-08

Practical, Cost-Effective Synthesis of Ubiquinones

#103
20070219164
2007-09-20

Pharmaceutical compound and method

#104
20070213398
2007-09-13

INHIBITORS OF PHOSPHATIDYL MYO-INOSITOL CYCLE

#105
20070207986
2007-09-06

Inositol pyrophosphates, and methods of use thereof

#106
20070179321
2007-08-02

PROCESS FOR THE PRODUCTION OF 4,4-DIPHENYLCYCLOHEXANOL

#107
20070179120
2007-08-02

Hydroxyl compounds and compositions for cholesterol management and related uses

#108
20070142653
2007-06-21

Inositolphospholipids and analogues: phosphatidylinositol products and processes

#109
20070129336
2007-06-07

Camphanylidene and phenylalkyl inositol polyphosphate compounds, compositions, and methods of their use

#110
20070105812
2007-05-10

Lipid analogs for inhibiting HIV-1 activity

#111
20070105811
2007-05-10

Lipid analogs for inhibiting the activity of hepatitis B antigen

#112
20070099870
2007-05-03

Lipid analogs for combating tumors

#113
20070082948
2007-04-12

Compounds and methods for delivery of prostacyclin analogs

#114
20070078182
2007-04-05

Compounds and methods for delivery of prostacyclin analogs

#115
20070078095
2007-04-05

Compounds and methods for delivery of prostacyclin analogs

#116
20070015735
2007-01-18

Water-dispersible carotenoids, including analogs and derivatives

#117
20060281715
2006-12-14

Phosphates of secondary alcohols

#118
20060241308
2006-10-26

Probe for measuring phytase activity

#119
20060229446
2006-10-12

Structural carotenoid analogs for the inhibition and amelioration of disease

#120
20060229281
2006-10-12

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#121
20060135765
2006-06-22

Antineoplastic ether lipid compounds

#122
20060116358
2006-06-01

Inositol pyrophosphates, and methods of use thereof

#123
20060106001
2006-05-18

Phytic citrate compounds and process for preparing the same

#124
20060105998
2006-05-18

Antiprotozoal ring-substituted phospholipids

#125
20060105996
2006-05-18

Inositolized phospholipids

#126
20060062726
2006-03-23

Glycerol ester derivative

#127
20050282901
2005-12-22

Compounds and methods for delivery of prostacyclin analogs

#128
20050272708
2005-12-08

Akt inhibitors, pharmaceutical compositions, and uses thereof

#129
20050250743
2005-11-10

Ammonium salts of inositol hexaphosphate, and uses thereof

#130
20050148675
2005-07-07

Practical, cost-effective synthesis of ubiquinones

#131
20050148517
2005-07-07

Carotenoid ether analogs or derivatives for controlling connexin 43 expression

#132
20050148042
2005-07-07

Hybrid phosphoinositide phospholipids: compositions and uses

#133
20050143475
2005-06-30

Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury

#134
20050113372
2005-05-26

Carotenoid analogs or derivatives for the inhibition and amelioration of disease

#135
20050090469
2005-04-28

Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease

#136
20050085540
2005-04-21

Compounds and methods for delivery of prostacyclin analogs

#137
20050080050
2005-04-14

Lipid analogs for treating viral infections

#138
20050075337
2005-04-07

Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease

#139
20050075316
2005-04-07

Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease

#140
20050065097
2005-03-24

Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury

#141
20050065096
2005-03-24

Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease

#142
20050059659
2005-03-17

Carotenoid analogs or derivatives for controlling C-reactive protein levels

#143
20050059635
2005-03-17

Carotenoid ester analogs or derivatives for controlling C-reactive protein levels

#144
20050049248
2005-03-03

Carotenoid ether analogs or derivatives for controlling C-reactive protein levels

#145
20050043278
2005-02-24

Hydroxyl compounds and compositions for cholesterol management and related uses

#146
20050037995
2005-02-17

Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury

#147
20050032802
2005-02-10

Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents

#148
20050026874
2005-02-03

Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease

#149
20050020543
2005-01-27

Hexa-citrated phytate and process of preparation thereof

#150
20050009930
2005-01-13

Carotenoid analogs or derivatives for controlling expression

#151
20050009788
2005-01-13

Carotenoid ester analogs or derivatives for controlling connexin 43 expression

#152
20050009758
2005-01-13

Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease

#153
20050004235
2005-01-06

Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease